Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit (ECRHIN-ICU)
Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit. A Multicenter Prospective Observational Study Comparing Nicardipine and Urapidil
Sponsor: University Hospital, Caen
Listed as NCT05155202, this observational or N/A phase trial focuses on Hypertensive Emergency and Hypoxemic Respiratory Failure and remains ongoing. Sponsored by University Hospital, Caen, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Mar 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2023 — Mar 2024 [monthly]
Recruiting
▶ Show 1 earlier version
-
Jan 2022 — Jun 2023 [monthly]
Recruiting
First recorded
Nov 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Caen
For direct contact, visit the study record on ClinicalTrials.gov .